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Abstract 
The depletion of three banned nitroimidazole drugs (dimetridazole (DMZ), metronidazole 
(MNZ) and ronidazole (RNZ)) was investigated in black tiger shrimp (Penaeus monodon) 
following in-water medication. The highest concentrations of residues were measured 
immediately after the 24 h immersion (day 0).  At this time, MNZ and MNZ-OH residues 
were measured in shrimp tissue samples at concentrations ranging from 361 – 4189 and 0.28 
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– 6.6 μg kg-1, respectively. DMZ and its metabolites HMMNI ranged in concentration 
between 31509 – 37780 and 15.0 – 31.9 μg kg-1, respectively. RNZ and HMMNI 
concentrations ranged 14530 – 24206 and 25.0 – 55 μg kg-1, respectively. MNZ, DMZ and 
RNZ were the more persistent marker residues and can be detected for at least eight days 
post-treatment. MNZ-OH was only detectable on day 0 following treatment with MNZ.  
HMMNI residues were only detectable up to day 1 (0.97 – 3.2 μg kg-1) or 2 (1.2 – 4.5 μg kg-1) 
following DMZ and RNZ treatment, respectively. The parent drugs, MNZ, DMZ and RNZ 
were still measureable on day 8 at 0.12 – 1.00, 40.5 – 55 and 8.8 – 18.7 μg kg-1, respectively. 
The study also investigated the stability of nitroimidazole residues under various cooking 
procedures (frying, grilling, boiling and boiling followed by microwaving). The experiments 
were carried out in shrimp muscle tissue containing both high and low concentrations of these 
residues. Different cooking procedures showed the impact on nitroimidazole residue 
concentration in shrimp tissue – their concentration depleted significantly, but partially, by 
boiling and/or microwaving but the compounds were largely resistant to conventional grilling 
or frying.  Cooking cannot therefore be considered as a safeguard against harmful 
nitroimidazole residues in shrimp. 
 
Keywords: nitroimidazole residues, dimetridazole, HMMNI, metronidazole, metronidazole-
OH, ronidazole, shrimp, persistence, stability, cooking, UHPLC-MS/MS 
 
Introduction 
Shrimp farming has increased significantly over the last couple of decades and by 
2007 exceeded the global catch of all marine shrimps (Valderrama and Anderson 2011). In 
2010, the value of shrimp production accounted for approximately 15% of the total value of 
internationally traded fishery products which made shrimp the largest single commodity in 
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terms of value (Anon. 2012). However, shrimp farming has faced serious disease outbreaks 
from viral, bacterial and parasitic infections causing significant economic loss (Chou et al. 
1995). For instance, diseases outbreaks have resulted in the collapse of the penaeid shrimp 
aquaculture industry in Taiwan in the late 1980s (Kautsky et al. 2000), caused a $750 million 
loss in 1993 in China and $210 million in 1995–1996 in India (Primavera 1998). Indeed, 
disease outbreaks have resulted in the dramatic decline in the production during 1994-2004. 
The protozoan parasites in shrimp that can cause diseases including several groups 
such as Microspora, Haplospora and Gregarina (Johnson 1995; Lightner 1996). For instance, 
microsporidians can cause a cotton shrimp disease (Hose et al. 1984) whereas the Haplospora 
group destroy the tissues of the shrimp digestive gland (Johnson 1995). Gregarines are a 
common intestinal parasite for shrimp. Some parasites in this group, such as Nematopsis 
penaeus, have been reported to cause severe damage in the gut mucosal epithelium of shrimp 
and associated with mortality and lesions (Fajer-Ávila et al. 2005). 
In contrast to terrestrial food producing animals, few veterinary medicines are licensed 
for treating aquaculture species (Bishop 2005). Consequently, there is a concern about the 
illegal application of veterinary drugs to prevent or to treat infectious diseases in aquaculture. 
Several studies were performed to evaluate effectiveness of antibiotics in different farmed 
aquaculture species (Clopton and Smith 2002; Smith and Clopton 2003; Fajer-Ávila et al. 
2005) as well as depletion of these antibiotics (Corliss 1979; Poapolathep et al. 2008).  The 
consumption of shrimps containing banned substances is of continuing concern and there is 
an ongoing need for knowledge on the persistence of residues in shrimp tissue for risk 
assessment purposes. 
Nitroimidazoles are known to be effective in the treatment of parasitic infections in 
aquaculture species, but currently metronidazole (MNZ) is licensed only for ornamental fish 
(Tojo and Santamarina 1998a; Tojo and Santamarina 1998b; Bishop 2005). Nitroimidazoles 
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and their corresponding hydroxy metabolites are suspected to be carcinogenic and mutagenic 
to humans (Raether and Hänel 2003). As a consequence the EU banned the use of 
nitroimidazole drugs (dimetridazole (DMZ), metronidazole (MNZ) and ronidazole (RNZ)) in 
food-producing animals or in products intended for human consumption under Regulation 
2377/90 (Anon. 1990), replaced by 470/2009 (Anon. 1990) and 37/2010 (Anon. 2010). DMZ, 
MNZ and RNZ are classified as prohibited pharmacologically active substances for which no 
MRL can be established as they constitute a hazard to the health of the consumer at whatever 
limit (Anon. 1990). For this reason, confirmation of the presence of dimetridazole, 
metronidazole and ronidazole residues or their corresponding hydroxy metabolites (namely 
HMMNI and metronidazole-OH) at any concentration must be considered as a violation of 
the EU regulation.  In order to protect a public health and harmonise trade, DMZ, MNZ, RNZ 
and their hydroxy metabolites have each been assigned a recommended concentration of 3 µg 
kg-1, for the performance of analytical methods, by the EU Reference Laboratory in Berlin 
(Anon. 2007).  
A number of animal studies with different species (laying hens, turkeys and pigs) 
employing different nitroimidazole drugs (dimetridazole, ipronidazole, metronidazole and 
ronidazole) have been carried out in the past (Polzer et al. 2004). However, there are no 
references in the peer-reviewed literature to the depletion studies of nitroimidazoles in farmed 
aquaculture species. Moreover, most information regarding veterinary drug residues in food is 
related to their concentrations in raw tissue, but most food of animal origin including 
aquaculture is consumed after cooking or processing. Therefore, knowledge of the impact of 
cooking on veterinary drug residues is important for more accurate dietary exposure 
assessment. A review of the peer reviewed literature has shown that relatively few studies on 
the effect of cooking on residues have been reported (Rose et al. 1999; Cooper and Kennedy 
2007; Mitrowska et al. 2007; Cooper et al. 2011). Furthermore, little is known about the 
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stability of nitroimidazole residues in food under conventional cooking conditions. To date, 
the assessment of their stability in food has been limited to the effects of various cooking 
procedures including boiling, frying and microwaving, on dimetridazole, ronidazole and their 
metabolite, namely HMMNI, in egg and chicken muscle (Rose et al. 1999). 
The objective of this study was to evaluate the elimination of dimetridazole, 
metronidazole and ronidazole residues in shrimp tissue following an in-water treatment and to 
determine the stability of these residues under various cooking procedures (frying, grilling, 
boiling and boiling followed by microwaving). 
 
Materials and methods 
Materials and reagents 
All chemicals used in this research were analytical grade or better.  Dimetridazole 
(DMZ), metronidazole (MNZ) and ronidazole (RNZ) were purchased from Sigma-Aldrich 
(Dublin, Ireland). HMMNI, metronidazole-OH (MNZ-OH), dimetridazole-d3 (DMZ-D3), 
HMMNI-d3, metronidazole-13C2,15N2 (MNZ-13C2,15N2), metronidazole-OH-d2 (MNZ-OH-
D2) and ronidazole-D3 (RNZ-D3) were purchased from Witega (Berlin, Germany). All 
standards and internal standards stock solutions were prepared at a concentration of 1 mg mL-
1 in MeOH and MeOH-D, respectively.  
Two complementary analytical methods covering the range 0.1 – 20 µg kg-1 (low 
residue method) and 20 – 10000 µg kg-1 (high residue method) were used in this study. A low 
residue method was reported previously (Gadaj et al. 2014), whereas an additional high 
residue procedure was developed and validated for the current study since the concentration 
of nitroimidazole residues detected in treated shrimp tissues at certain time points (day 0 
(MNZ), day 0 – 8 (DMZ) and day 0 – 4 (RNZ)) exceeded the range of the initial method used. 
Consequently, two different working standards mixes were required for calibrations and 
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controls. A high mixed calibration range was prepared at concentrations of 0.2 (std 1), 0.5 
(std 2), 1 (std 3), 2.5 (std 4), 5 (std 5), 10 (std 6), 25 (std 7), 50 (std 8) and 100 (std 9) µg mL-1 
in MeOH, by serial dilution of the stock solutions. The preparation of standards for a low 
calibration range is described elsewhere (Gadaj et al. 2014). An intermediate and a working 
internal standard mix solution were prepared at 100 and 5 µg mL-1 in MeOH-D, 
respectively. All standards and internal standards sock solutions, and intermediate mix 
solutions were found to be stable for at least one year when stored at -20 °C. Working 
calibration standard and a working internal standard mix solutions were found to be stable 
for at least three months when stored at -20 °C. 
Analysis of nitroimidazole residues in test samples 
A finely chopped portion of each shrimp sample 1 g ± 0.01 g was weighed into a 50 
mL polypropylene tube. Samples were fortified with 50 µL of a 5 µg mL-1 internal standard 
mix solution and left to stand for 15 min. A 12 mL volume of MeCN was added into each 
tube. The tube contents were homogenised using an Ultra-Turrax probe blender for 30 s and 9 
mL of H2O was subsequently added. After vortexing for 60 s, 1 g of NaCl and 4 g of MgSO4 
was added to tubes, which were then shaken vigorously by hand for a minimum of 60 s. 
Samples were centrifuged at 3500 rpm (2842 × g) for 12 min at 4 ºC. 1 mL of the supernatants 
were transferred to clean empty 5 mL glass tubes. Following the addition of 1 mL of H2O, 
samples were vortexed for 60 s. Extracts were filtered through 0.2 µm PTFE 13 mm Millex-
FG syringe filters (Millipore, Cork, Ireland) and 2 µL were injected onto the UHPLC-MS/MS 
system. The UHPLC-MS/MS conditions are described in detail elsewhere (Gadaj et al. 2014).  
 Preparation of extracted matrix calibrants and recovery control checks 
Extracted matrix calibrants for the high residue method were prepared by fortifying 
negative shrimp samples (1 g ± 0.01 g) prior to extraction with 100 µL of each calibration 
standard solutions (standards 1 to 9) to give curves in the range 20 – 10000 µg kg-1. An 
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additional four blank samples (recovery controls) were spiked after extraction to monitor for 
loss of analytes during extraction. Briefly, 6 mL of the supernatants were transferred to clean 
empty 15 mL polypropylene tubes and two tubes were spiked with 50 µL of std 2 (0.5 µg mL-1) 
and two with 50 µL of std 8 (50 µg mL-1). Samples were vortexed for 60 s and 1 mL of the 
extracts were transferred to clean empty 5 mL glass tubes. The preparation of extracted matrix 
calibrants and controls checks for the low residue method is described elsewhere (Gadaj et al. 
2014).   
Method validation 
 A low residue method validation was reported previously (Gadaj et al. 2014). Briefly, 
the method was validated according to the EU Commission Decision 2002/657/EC criteria 
and the following performance studies were carried out: selectivity, specificity, linearity of 
calibration curve, working range of the method, within laboratory repeatability (WLr), within 
laboratory reproducibility (WLR), accuracy, precision, decision limit (CCα), detection 
capability (CCβ), matrix effects, absolute recovery and stability. Validation was carried out at 
1.5, 3.0 and 4.5 µg kg-1. 
 Accuracy and precision of the method ranged from 96 to 103% and 1.6 to 14.0%, 
respectively. The CCα values for all nitroimidazoles and their corresponding hydroxy 
metabolites were below the recommended concentration of 3 µg kg-1, ranging 0.07 – 1.0 μg 
kg-1 depending on the analyte. 
In the case of a high residue method, the following analytical method performance 
parameters were investigated: linearity of calibration curve, working range of the method, 
intra- and inter-assay repeatability, accuracy, precision and absolute recovery. Both intra- and 
inter-assay repeatability studies were carried out by the same analyst. In total six runs were 
executed for the validation study. Five portions coming from the same negative control test 
material were used for the establishment of intra-assay repeatability, whereas two portions 
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were used for the establishment of inter-assay repeatability, and the method was repeated on 
five separate days. The validation study was carried out by fortifying shrimp tissue samples at 
40, 500 and 5000 μg kg-1.   
Shrimp experimental treatments and sampling 
All shrimp treatment studies were carried out at the Shrimp Biotechnology Business 
Unit (SBBU), Thailand.  Black tiger shrimps (Penaeus monodon) were obtained from a farm 
in the Chachoengsao province. Upon arrival, the experimental shrimps were acclimatised in a 
2000 L tank and reared with commercial feed until they reached a weight of 20–25 g. The 
shrimp were fed four times daily at a 2% rate of total body weight.  
A total of four 390 L tanks per drug were supplied with dimetridazole, metronidazole 
and ronidazole, respectively, at a concentration of 50 mg L-1 (volume of 353 L) and a further 
two tanks with non-medicated static water system. The dose aimed in this bath treatment 
study was a therapeutic dose as recommended for metronidazole by the Veterinary Formulary 
(Bishop 2005). Aquaria conditions were maintained as the following: pH 7.5 – 8.5, dissolved 
oxygen > 5 mg L-1, temperature 27 – 30 ºC, salinity 15 g L-1, ammonia-nitrogen < 0.03 mg N 
L-1, nitrite-nitrogen < 1 mg N L-1 and alkalinity 80 – 150 mg CaCO3 L-1. Thirty five shrimp 
were immersed for 24 h in each tank containing a nitroimidazole drug.  
After the immersion, shrimps were transferred to normal sea water for eight days and 
collected at specified intervals: immediately (d0), day 1 (d1), day 2 (d2), day 4 (d4) and day 8 
(d8). At each sampling time, six shrimp per tank (both medicated and non-medicated) were 
collected, rinsed with normal sea water, and stored in bags at -20 °C prior to delivery in dry 
ice. The untreated shrimps were taken from original stock prior to the treatment to be used as 
a blank tissue. Upon arrival to Teagasc, shrimps were peeled and deveined manually. Shrimps 
were stored individually in 50 mL polypropylene tubes at -70 °C until assayed, whereas the 
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shrimps taken from original stock prior to the treatment were homogenised using a 
mechanical blender and stored in a bag at -70 °C.  
 Cooking of the incurred shrimp tissue 
Methodology 
Dimetridazole, metronidazole and ronidazole-treated shrimps from two withdrawal 
time points (d0 and d8 (DMZ), d0 and d1 (MNZ), and d1 and d8 (RNZ)) were selected (n = 
12 per time point). To mimic domestic cooking practices, individual intact shrimps (4.60 – 
11.82 g) were subjected to one of the following cooking procedures: frying (shallow), grilling 
(broiling), boiling and boiling followed by microwaving (to mimic preparation of supermarket 
ready-meals), and were analysed both raw and cooked using an UHPLC-MS/MS method 
within a single analysis. To minimise variable changes in weight due to water loss during 
sample freeze-thawing, the 2 g aliquots of raw tissue were weighed out at the same time as the 
aliquots of cooked shrimp. Samples were then refrozen at -70 °C until assayed. Six replicate 
shrimps were tested for each of four cooking procedures. Negative controls were included to 
prove dimetridazole, metronidazole and ronidazole residues did not form during cooking. 
Negative controls, namely, two raw peeled king prawns purchased from a local supermarket 
were included for each cooking method, tested before and after cooking.  
Boiling 
Each of the pre-weighed shrimps was placed in an open 35 mL glass tube containing 
15 mL of water sitting in a pot of boiling water on a domestic ceramic hob. Hob heat was 
reduced and the shrimps were allowed to simmer for 5 min. After 5 min, water in the tubes 
was decanted to clean polypropylene containers and allowed to cool to room temperature 
before measuring the total volume of water recovered. The cooked shrimps were placed 
immediately on tissue paper at 4 °C to halt the cooking process and remove excess water. 
After 30 min the cooked shrimps were weighed. 
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Boiling followed by microwaving 
Pre-weighed shrimps were boiled as described above including collection of water. 
After 30 min cooling at 4 °C, the boiled shrimp was placed in a microwavable container 
covered with cling film and microwaved on full power (800W oven) for 4 min.  Cooked 
shrimps were again cooled for 30 min at 4 °C on tissue paper and reweighed. 
Grilling 
Pre-weighed shrimps were brushed lightly with a minimal amount of sunflower oil to 
prevent burning and placed on a rack under a pre-heated domestic grill (high temperature) and 
grilled for 2 min each side, turning once (this standardised time may be adjusted depending on 
average size of the shrimps and observed time to cook completely). After cooking, excess oil 
was removed gently with tissue paper and shrimps were cooled for 30 min at 4 °C on tissue 
paper to halt the cooking process and reweighed. 
Frying 
Pre-weighed shrimps were placed in a pre-heated hot frying pan containing a minimal 
amount of sunflower oil to prevent burning. Shrimps were fried for 1.5 min on each side, 
turning once. After cooking, shrimps were cooled for 30 min at 4 °C and re-weighed. 
 
Results and discussion 
Analytical methodology 
Several analytical methods have been reported for nitroimidazole residue analysis in 
different food matrices based on LC-MS/MS detection and they were found to be capable of 
the detection of target analytes in the low µg kg-1 region, below the recommended 
concentration (Mottier et al. 2006; Peters et al. 2009; Smith et al. 2009; Mahugo-Santana et 
al. 2010; Mitrowska et al. 2010; Kaufmann et al. 2011; Gadaj et al. 2014). 
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Shrimp samples from the immersion treatment experiment were initially analysed 
using the method that was previously developed by Gadaj et al. (2014) for the analysis of 
nitroimidazole residues in aquaculture tissue in the range of 0.1 – 20 μg kg-1. The analysis of 
shrimp tissue samples that were collected immediately (d0) after medication with MNZ, and 
day 0 – 8 and 0 – 4 after medications with DMZ and RNZ, respectively, gave the 
concentration of the parent drug exceeding the range of the analytical method used. Therefore, 
a new method for the analysis of high residue samples, covering the range 20 – 10000 μg kg-1 
was developed and validated.  
The linearity of the method was evaluated over the range 20 – 10000 µg kg-1 during 
validation studies. The linearity of the curves (measured as R2) was satisfactory and greater 
than 0.99. Shrimp samples were fortified at levels of 40, 500 and 5000 μg kg-1. The results of 
the validation study collected in Table S2, supplementary data, show that the accuracy and 
precision were in the ranges of 95 – 114% and 1.0 – 12.4%, respectively. Mean recoveries for 
nitroimidazole drug residues and their hydroxy metabolites were calculated by comparing the 
concentrations in fortified samples with concentrations in control samples spiked post-
extraction to be 91 ± 5.9% (DMZ), 88 ± 6.1% (HMMNI) and 90 ± 4.1% (MNZ), 84 ± 8.5% 
(MNZ-OH) and 93 ± 7.1% (RNZ). Recovery was based on data collected from routine 
application of the method (n = 11 analytical runs).  
 
Reproducibility of analysis 
 Assay performance was also assessed by reproducibility of the analysis (n = 3) of 
randomly selected shrimp samples subjected to various cooking procedures (boiling, frying 
and grilling) and containing dimetridazole, metronidazole and ronidazole residues, 
respectively. The precision was in the range of 1.5 – 16.4%, exceeding 15% only in one case 
(Table S3, supplementary data). The EU Commission Decision 2002/657/EC states that 
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precision calculated as CV should be as low as possible and not higher than 23% for mass 
fractions over 100 μg kg-1.  Therefore, the results obtained in this study were well within the 
guideline and demonstrate high reproducibility of the analysis. 
 
Evaluation of persistence of metronidazole residues in shrimp tissue 
The depletion of DMZ, MNZ and RNZ residues and their hydroxy metabolites 
(HMMNI and MNZ-OH) were profiled over time as presented in Figure 1. The study served 
to identify the most suitable nitroimidazole drug marker residues and to investigate the 
persistence of residues as a function of withdrawal period. In this context residue 
concentrations at five different time points (d0, d1, d2, d4 and d8) post-treatment were 
examined in shrimp muscle tissue. 
The maximum concentration of nitroimidazole residues measured within the 
individual shrimp tissue were 361 – 4189 μg kg-1, 31509 – 37780 μg kg-1 and 14530 – 24206 
μg kg-1 (n = 24) in the case of MNZ, DMZ and RNZ, respectively, and occurred on day 0 
post-treatment. Residue concentrations rapidly depleted in tissue samples at later time points 
(Figure 1). However, for at least eight days post-treatment, nitroimidazole residues were 
detectable in all medicated shrimp tissues. MNZ-OH residues were only detectable on day 0 
post-treatment and the concentrations measured were very low in comparison with MNZ 
level, and ranged 0.28 – 6.6 μg kg-1 (n = 12). Similarly, HMMNI residues were only 
detectable up to day 1 (15.0 – 31.9 μg kg-1) or 2 (2.4 ± 0.80 μg kg-1) (n = 24) following DMZ 
and RNZ treatment, respectively. The CCα of the low residue method were as follows: 0.11 
μg kg-1 (DMZ), 1.0 μg kg-1 (HMMNI), 0.07 μg kg-1 (MNZ), 0.13 μg kg-1 (MNZ-OH) and 0.33 
μg kg-1 (RNZ) (Gadaj et al. 2014). It can be concluded that even if nitroimidazole drug level 
in shrimp tissue is decreasing rapidly in the case of the treatment with DMZ, MNZ and RNZ, 
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the parent drugs themselves are the more persistent marker residues and can still be detected 
after eight days post-medication.  
There have been no reports on the persistence of nitroimidazole drug residues in 
farmed aquaculture species following treatment. Rodriguez et al. (2011) reported on the 
uptake of MNZ in Artemia (brine shrimp) at different stages of development. Artemia were 
treated using 50 mg MNZ per L as an in-water treatment at room temperature (26 – 28 ºC) for 
3 h. This study showed that medication levels of 85 – 143 mg kg-1 incurred in Artemia. The 
results from the current study showed a lower incursion level of MNZ in shrimp. This fact 
may be explained by the different capacities of various crustacean species to accumulate 
metronidazole. Rodriguez et al. (2011) did not report on the depletion of residues over time 
because samples were collected immediately post-treatment. No further studies have been 
reported in fish or crustaceans. Polzer et al. (2004) reported on the depletion of nitroimidazole 
residues in turkey muscle. These studies showed that DMZ and the HMMNI metabolite 
rapidly depleted in turkey breast meat from 96 – 2000 μg kg-1 (day 0) to < 0.8 μg kg-1 (day 1) 
and from approximately 1000 μg kg-1 (day 0) to 0.1 μg kg-1 (day 3), respectively. MNZ and 
MNZ-OH residues were also monitore  in muscle and liver tissue but were < 1 μg kg-1 and 
not detectable at day 1.  
Stability during cooking 
Since shrimp is usually cooked before consumption and there is also a wide range of ready-
meals containing shrimp available on the market (Radovnikovic et al. 2013), it is reasonable 
to assess the stability of drug residues during various cooking conditions. In the current study, 
the stability of dimetridazole, metronidazole and ronidazole residues in shrimp tissue under 
frying, grilling, boiling and boiling followed by microwaving was examined. Tissue samples 
coming from shrimp treated with DMZ, MNZ and RNZ, and containing mainly residues of 
the parent drug in the case of MNZ and both parent drug and its hydroxy metabolite 
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(HMMNI) in the case of DMZ and RNZ, were used in the study. Changes in nitroimidazole 
drug and the corresponding hydroxy metabolite residues concentrations for each cooking 
method are shown in Tables 1 – 6. The concentrations detected in raw (uncooked) tissues 
were adjusted for sample weight changes resulting from the cooking procedures to give 
concentrations ‘expected after cooking’. These expected concentrations were then compared 
with the concentrations detected after cooking. It should be highlighted that due to the 
limitations in weight of individual shrimps, only one analysis could be carried out for each 
raw and cooked sample.  Therefore, statistical interpretation of the results is difficult and 
could only be based on the analytical precision of the method, described in Table S2 and 
elsewhere (Gadaj et al. 2014).  However, repeat analysis was carried out on raw shrimp tissue 
samples tested during the depletion studies and showed good agreement between results on 
different days. The method reproducibility was additionally assessed on randomly selected 
cooked samples as described in detail in the paragraph above.   
Small reductions in MNZ concentrations of up to 25% were evident in the frying and 
grilling experiments in shrimp tissue samples from the high level treatment group (Table 1). 
Further frying and grilling studies were carried out using shrimp samples containing MNZ 
residues in the low range from 0.32 to 12.5 μg kg-1. Apparent small increases in MNZ were 
observed, in two out of three samples following frying. In contrast, grilling the low 
concentration shrimps showed that MNZ concentrations consistently increased to a greater 
degree (mean 155% increase). It should be noted that decreases in water content of samples 
were monitored during the cooking processes and were factored into residue concentration 
calculations. It could be postulated that grilling may result in the release of additional tissue-
bound MNZ residues; however, as increases were not seen in the high concentration samples 
following cooking, this cannot be claimed with any certainty. 
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Additional cooking studies were conducted to investigate the impact of boiling and 
boiling combined with microwaving on MNZ concentration in shrimp (Table 2). Mean MNZ 
residues were found to decrease by 42% and 56% in the high and low concentration groups 
after boiling, respectively. Subsequent analysis showed that 36% and 31% of MNZ residues 
in shrimps from the high and low concentration groups were extracted into the water. 
Following the combined boiling and microwaving treatment, mean MNZ concentrations 
decreased by 84% and 89% in the high and low concentration groups, respectively. Similarly, 
analysis showed that 34% and 36% of MNZ residues from the high and low concentration 
groups were extracted into the water.  
 MNZ-OH concentrations were also monitored during the cooking studies but only two 
samples contained residues and these were reduced marginally following cooking. MNZ-OH 
does not occur as a major residue in shrimp and does not appear to form during cooking. 
In the case of DMZ, the frying experiment showed a small mean reduction of 12% in 
shrimp tissue samples from the high level treatment group (Table 3). A similar reduction of 
13% was observed in the high concentration grilling experiment. Further frying and grilling 
studies were carried out using shrimp samples containing DMZ residues in the low range 
from 54 to 160 μg kg-1. Similar small reductions in DMZ residues were evident in half of the 
samples, although small apparent increases of up to 11% were evident in the other half.  
Additional cooking studies were conducted to investigate the impact of boiling and 
boiling combined with microwaving on DMZ concentration in shrimp (Table 4). Mean DMZ 
residues were found to decrease by 35% and 54% in the high and low concentration groups 
after boiling, respectively. Subsequent analysis showed that 42% and 40% of DMZ residues 
in shrimps from the high and low concentration groups were extracted into the water. 
Following the combined boiling and microwaving treatment, mean DMZ concentrations 
decreased by 52% and 65% in the high and low concentration groups, respectively. Similarly, 
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analysis showed that 45% and 55% of DMZ residues from the high and low concentration 
groups were extracted into the water.  
 HMMNI concentrations, following DMZ treatment, were also monitored during the 
cooking studies but only samples from the high level treatment group contained detectable 
residues.  This showed that frying, grilling, boiling and boiling followed by microwaving 
reduced mean HMMNI residues in shrimp muscle tissue by 17%, 14%, 45% and 44%, 
respectively. Moreover analysis showed that 40% of HMMNI residues were extracted into the 
water in both boiling and boiling followed by microwaving experiment. 
In the case of RNZ (Table 5), mean reductions of 7% and 14% were observed 
following frying and grilling of shrimp samples containing high levels of RNZ, respectively. 
Further frying and grilling studies were carried out using shrimp samples containing RNZ 
residues in the low range from 2.9 to 15.7 μg kg-1. One out of three low range samples 
showed a large increase in RNZ following frying, whilst grilling resulted in consistent 
increases (mean 108%). Additional cooking studies were conducted to investigate the impact 
of boiling and boiling combined with microwaving on RNZ concentration in shrimp muscle 
tissue (Table 6). Mean RNZ residues were found to decrease by 43% and 15% in the high and 
low concentration groups after boiling, respectively. Subsequent analysis showed that 49% 
and 70% of RNZ residues from the high and low concentration groups were extracted into the 
water. Following the combined boiling and microwaving treatment, mean RNZ 
concentrations decreased by 73% and 91% in the high and low concentration groups 
respectively. Similarly, analysis showed that 43% and 75% of RNZ residues from the high 
and low concentration groups were extracted into the water. 
 HMMNI concentrations, following RNZ treatment, were also monitored during the 
cooking studies but only samples from the high level treatment group contained residues. This 
showed that frying, grilling and boiling followed by microwaving increased mean HMMNI 
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residues in the shrimp tissue by 140%, 112% and 920%, respectively, whereas boiling 
reduced them by 7%. Moreover, analysis showed that HMMNI residues were extracted into 
the water, to a small but approximately equal degree, in both boiling and boiling followed by 
microwaving experiment (Table 6). This striking effect of microwaving causing a large 
increase in HMMNI residues following RNZ treatment (but not DMZ treatment) cannot be 
easily explained. As suggested previously by Rose et al. (1999), the effect of some conversion 
from parent drug to its metabolite might occur during various heat processing conditions and 
superimpose over the other effects. Given that microwaving was applied to single, boiled 
shrimps with no accompanying liquid or sauce, causing a major loss of water and potentially 
higher internal temperatures than would be experienced in normal domestic cooking of 
shrimps in a meal of mixed ingredients, it is possible this increase in HMMNI following 
microwaving may not be replicated in the kitchen. However, there is a clear pattern across all 
cooking methods of HMMNI production in shrimps when high levels of RNZ are present. 
This is unlikely to represent a significant safety issue since HMMNI concentrations derived 
from RNZ following cooking represent less than 3% of the accompanying RNZ 
concentrations across all cooking metho s.   
A review of the peer reviewed literature showed that no cooking study has been 
carried out on nitroimidazole drug residues in shrimp or any other aquaculture tissue or food 
material. Rose et al. (1999) reported on the effect of frying, boiling and microwaving on 
dimetridazole, ronidazole and HMMNI (metabolite of each drug) residues in egg and chicken 
muscle. As was also seen in the current study, the analysis of water used for boiling showed 
that residues of DMZ and its metabolite were extracted from meat to water. Similarly, the 
results of frying and microwaving experiments showed reductions in residues concentrations 
which were accounted for by losses in the juices expressed during cooking. In the case of 
RNZ, a reduction of residue concentrations was observed following microwaving. 
D
ow
nl
oa
de
d 
by
 [T
he
 L
ibr
ary
 at
 Q
ue
en
's U
niv
ers
ity
] a
t 0
4:1
5 1
5 D
ec
em
be
r 2
01
4 
Ac
ce
pte
d M
an
us
cri
pt
18 
 
 
Conclusions 
The results of the current study demonstrate that dimetridazole, metronidazole and 
ronidazole are the major residues found in shrimp muscle tissue following an in-water 
medication. Nitroimidazole hydroxy metabolites were also detected, but only at earlier 
withdrawal periods. The depletion profiles of the studied drugs show that DMZ and RNZ 
occur at higher concentrations and are more persistent than MNZ in shrimp following an in-
water medication treatment. 
The effect of different cooking procedures was investigated and showed that a boiling-
microwaving combination treatment resulted in the greatest reduction of residues in tissue, 
followed by boiling, then grilling and frying which had similar and less pronounced effects on 
residue concentrations. There was no clear difference in the stability of the three 
nitroimidazoles – DMZ was more resilient to the most severe cooking method (boiling and 
microwaving) than MNZ and RNZ, although DMZ residues in shrimp meat were still 
degraded by 52 – 65%. The results indicate that boiling of shrimps prior to further cooking 
can reduce nitroimidazole exposure, primarily via partial extraction of residues into the water, 
but will not eliminate residues. Indeed there is the potential that nitroimidazole residues may 
be converted to more toxic substances following frying, grilling or microwaving. Therefore, 
cooking cannot be considered as a safeguard against ingestion of harmful nitroimidazole 
residues. 
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Figure 1: Depletion profile of (A) dimetridazole, (B) metronidazole and (C) ronidazole in 
shrimp tissue (95% CL, <i>n</i> = 24 results per time point).  
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Table 1 
Effect of frying and grilling on the concentration of MNZ and MNZ-OH residues in shrimp tissue. 
 
Sample Weight 
 (g) 
  Residue 
Before After Metronidazole Metronidazole-OH 
Raw 
 (μg kg-1)  
Cooked 
 (μg kg-1)   
Residue 
change 
 (%) 
Raw  
(μg kg-1)  
Cooked  
(μg kg-1)   
Residue 
change 
 (%) 
Expected Observed Expected Observed 
Frying (high residue) 
1 7.08 5.75 2239 2757 2327 -16 ND N/A ND N/A 
2 7.44 6.10 1238 1510 1509 0 ND N/A ND N/A 
3 9.34 7.67 734 894 861 -4 ND N/A ND N/A 
Frying (low residue) 
4 8.65 6.46 1.9 2.6 1.1 -59 ND N/A ND N/A 
5 7.81 6.23 1.6 2.0 2.4 +17 ND N/A ND N/A 
6 5.23 4.09 1.8 2.4 2.6 +9 ND N/A ND N/A 
Grilling (high residue) 
7 7.50 5.15 794 1156 960 -17 ND N/A ND N/A 
8 7.19 4.65 2892 4472 3334 -25 ND N/A ND N/A 
9 5.30 3.36 4189 6608 5883 -11 8.1 12.7 10.7 -16 
Grilling (low residue) 
10 6.88 4.18 0.69 1.1 3.1 +176 ND N/A ND N/A 
11 7.41 4.87 0.39 0.59 2.1 +251 ND N/A ND N/A 
12 7.44 4.95 0.32 0.48 0.66 +37 ND N/A ND N/A 
Notes: Expected concentrations are corrected for weight loss during cooking. ND, None detected. N/A, Not applicable. 
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Table 2 
Effect of boiling and boiling followed by microwaving on the concentration of MNZ and MNZ-OH residues in shrimp tissue. 
 
Sample Weight  
(g) 
Residue 
Before After Metronidazole Metronidazole-OH 
Raw  
(μg 
kg-1) 
Cooked  
(μg kg-1)   
Water/juices 
(μg kg-1)   
Residue 
change 
including 
water/juices  
(%) 
Raw  
(μg 
kg-1)  
Cooked  
(μg kg-1)   
Residue 
change 
 (%)     
Expected Observed Expected Observed 
Boiling (high residue) 
13 10.95 7.46 870 1277 764 187 -9 ND N/A ND N/A 
14 6.31 4.14 1657 2526 1364 256 -9 ND N/A ND N/A 
15 9.11 6.12 830 1235 750 185 -1 ND N/A ND N/A 
Boiling (low residue) 
16 5.70 3.46 1.4 2.3 0.93 0.19 -25 ND N/A ND N/A 
17 8.82 6.21 12.5 17.7 5.5 1.2 -53 0.12 0.17 0.13 -24 
18 7.83 5.37 4.5 6.5 4.0 0.94 +3 ND N/A ND N/A 
Boiling followed by microwaving (high residue) 
19 9.15 1.75 717 3748 353 104 -66 ND N/A ND N/A 
20 8.01 2.34 1245 4262 1005 213 -44 ND N/A ND N/A 
21 8.95 1.55 931 5376 852 241 -39 ND N/A ND N/A 
Boiling followed by microwaving (low residue) 
22 8.47 1.42 1.8 10.9 0.96 0.31 -58 ND N/A ND N/A 
23 8.48 1.84 0.66 3.0 0.39 0.13 -52 ND N/A ND N/A 
24 11.29 1.93 1.4 8.4 0.97 0.40 -49 ND N/A ND N/A 
Notes: Expected concentrations are corrected for weight loss during cooking. ND, None detected. N/A, Not applicable. 
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Table 3 
Effect of frying and grilling on the concentration of DMZ and HMMNI residues in shrimp tissue. 
 
Sample Weight          
(g) 
  Residue 
Before After Dimetridazole HMMNI 
Raw       
(μg kg-1)  
Cooked               
(μg kg-1)   
Residue 
change        
(%) 
Raw       
(μg kg-1)  
Cooked               
(μg kg-1)   
Residue 
change         
(%) 
Expected Observed Expected Observed 
Frying (high residue) 
25 7.73 6.22 34668 43085 38907 -10 21.9 27.2 23.8 -13 
26 5.44 4.42 36054 44374 40451 -9 23.0 28.3 21.6 -24 
27 7.50 5.81 37780 48769 40349 -17 21.0 27.1 23.1 -15 
Frying (low residue) 
28 5.36 3.90 83 114 101 -12 ND N/A ND N/A 
29 7.62 5.83 54 70 78 +11 ND N/A ND N/A 
30 5.47 3.92 54 75 78 +3 ND N/A ND N/A 
Grilling (high residue) 
31 8.16 4.90 32323 53827 44958 -16 32.2 54 40.4 -25 
32 11.82 8.23 33509 48126 47766 -1 39.2 56 61 8 
33 6.50 3.60 33239 60015 46875 -22 33.6 61 45.7 -25 
Grilling (low residue) 
34 8.70 5.96 160 233 249 +7 ND N/A ND N/A 
35 7.39 5.08 95 139 111 -20 ND N/A ND N/A 
36 11.59 8.00 110 159 136 -15 ND N/A ND N/A 
Notes: Expected concentrations are corrected for weight loss during cooking. ND, None detected. N/A, Not applicable. 
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Table 4 
Effect of boiling and boiling followed by microwaving on the concentration of DMZ and HMMNI residues in shrimp tissue. 
 
Sampl
e 
Weight        
(g) 
Residue 
Befor
e 
Afte
r 
Dimetridazole HMMNI 
Raw    
(μg 
kg-1)  
Cooked             
(μg kg-1)   
Water/juic
es          
(μg kg-1)   
Residue 
change 
including 
water/juic
es          
(%) 
Ra
w     
(μg 
kg-
1)  
Cooked             
(μg kg-1)   
Water/juic
es          
(μg kg-1)   
Residue 
change 
including 
water/juic
es          
(%) 
Expect
ed 
Observ
ed 
Expect
ed 
Observ
ed 
Boiling (high residue) 
37 6.24 3.58 34484 60107 32331 
7780 +5 11.3 19.7 8.6 2.3 
-10 
38 8.03 5.41 32140 47704 34177 
7422 +13 19.5 28.9 16.8 4.3 
-3 
39 10.11 7.19 33328 46862 31978 
6998 +4 25.3 35.6 22.4 5.1 
-3 
Boiling (low residue) 
40 7.76 5.15 118 178 92 18.6 -19 ND N/A ND ND N/A 
41 7.02 4.40 57 91 48.2 11.8 -2 ND N/A ND ND N/A 
42 5.60 3.10 77 139 44.6 15.3 -20 ND N/A ND ND N/A 
Boiling followed by microwaving (high residue) 
43 7.33 2.28 33659 108210 49198 
6694 -10 34.8 112 62 6.9 
-1 
44 7.01 1.94 34434 124424 58567 
7023 -8 32.7 118 67 6.2 
-2 
45 7.12 2.14 31509 104834 54102 
6395 -4 88 293 167 14.0 -8 
Boiling followed by microwaving (low residue) 
46 6.74 2.28 85 252 96 25.3 +6 ND N/A ND ND N/A 
47 10.76 2.61 91 375 144 25.2 -16 ND N/A ND ND N/A 
48 7.55 1.58 69 330 99 16.2 -19 ND N/A ND ND N/A 
Notes: Expected concentrations are corrected for weight loss during cooking. ND, None detected. N/A, Not applicable. 
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Table 5 
Effect of frying and grilling on the concentration of RNZ and HMMNI residues in shrimp tissue. 
 
Sample Weight          
(g) 
  Residue 
Before After Ronidazole HMMNI 
Raw       
(μg kg-1)  
Cooked               
(μg kg-1)   
Residue 
change         
(%) 
Raw       
(μg kg-1)  
Cooked               
(μg kg-1)   
Residue 
change         
(%) 
Expected Observed Expected Observed 
Frying (high residue) 
49 7.30 5.64 5044 6528 5997 -8 10.7 13.8 34.8 151 
50 7.76 6.81 5065 5771 6113 +6 11.9 13.6 19.1 41 
51 9.11 6.43 5438 7704 6260 -19 8.4 11.9 38.9 227 
Frying (low residue) 
52 5.14 3.93 9.5 12.4 11.6 -6 ND N/A ND N/A 
53 7.11 5.76 14.1 17.4 17.1 -2 ND N/A ND N/A 
54 4.71 3.27 3.8 5.5 10.5 +89 ND N/A ND N/A 
Grilling (high residue) 
55 6.60 4.29 4778 7351 5708 -22 13.1 20.2 30.7 52 
56 5.68 3.57 4415 7025 5865 -17 7.8 12.4 33.5 170 
57 8.96 6.16 4465 6495 6317 -3 8.2 11.9 25.7 115 
Grilling (low residue) 
58 5.97 3.69 6.4 10.4 12.6 +21 ND N/A ND N/A 
59 6.70 4.37 2.9 4.4 11.9 +168 ND N/A ND N/A 
60 6.80 4.50 4.0 6.0 14.1 +136 ND N/A ND N/A 
Notes: Expected concentrations are corrected for weight loss during cooking. ND, None detected. N/A, Not applicable. 
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Table 6 
Effect of boiling and boiling followed by microwaving on the concentration of RNZ and HMMNI residues in shrimp tissue. 
 
Sampl
e 
Weight        
(g) 
Residue 
Befor
e 
Afte
r 
Ronidazole HMMNI 
Ra
w     
(μg 
kg-
1)  
Cooked             
(μg kg-1)   
Water/juic
es          
(μg kg-1)   
Residue 
change 
including 
water/juic
es          
(%) 
Ra
w     
(μg 
kg-
1)  
Cooked             
(μg kg-1)   
Water/juic
es          
(μg kg-1)   
Residue 
change 
including 
water/juic
es          
(%) 
Expecte
d 
Observe
d 
Expecte
d 
Observe
d 
Boiling (high residue) 
61 8.85 5.74 4373 6743 4030 
998 +5 7.1 10.9 14.8 4.9 170 
62 7.95 4.58 4645 8063 4321 
1038 +4 14.1 24.5 18.0 5.9 
68 
63 6.40 3.65 4509 7905 4392 
872 +8 12.4 21.7 15.1 4.0 
57 
Boiling (low residue) 
64 6.85 4.30 13.2 21.0 13.5 
3.7 +42 ND N/A ND ND N/A 
65 8.63 6.07 9.2 13.1 12.5 3.5 +66 ND N/A ND ND N/A 
66 9.28 6.23 14.2 21.2 20.5 
4.1 +56 ND N/A ND ND N/A 
Boiling followed by microwaving (high residue) 
67 9.64 2.13 5758 26059 6102 
1301 -39 11.4 52 738 7.7 
1442 
68 6.89 1.71 4895 19725 8868 
856 -12 12.9 52 393 4.6 
743 
69 9.31 1.79 3646 18962 2508 
968 -38 9.9 51 450 5.0 865 
Boiling followed by microwaving (low residue) 
70 6.60 1.22 15.7 85 11.0 
4.5 -13 ND N/A ND ND N/A 
71 6.26 1.19 8.6 45.0 1.3 4.0 +26 ND N/A ND ND N/A 
72 6.20 1.06 5.8 34.2 3.8 2.8 +36 ND N/A ND ND N/A 
Notes: Expected concentrations are corrected for weight loss during cooking. ND, None detected. N/A, Not applicable. 
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Table S1 
UHPLC-MS/MS conditions. 
 
Analyte TRa 
(min) 
Transition 
(m/z) 
Dwell 
time 
(s) 
Cone 
(V) 
CEb 
(eV) 
ISc 
DMZ 2.67 141.9 → 96.0d 0.075 23 
 
15 DMZ-D3 
 141.9 → 81.0 22 
DMZ-D3 2.64 144.9 → 99.0 0.075 25 15 IS 
HMMNI 1.81 157.9 → 139.9d 0.020 20 12 HMMNI-D3 
 157.9 → 55.1 17 
HMMNI-D3 1.79 160.9 → 142.9 0.020 20 12 IS 
MNZ-OH 1.46 187.9 → 123.0d 0.100 21 12 MNZ-OH-D2 
187.9 → 126.0 16 
MNZ-OH-D2 1.46 189.9 → 128.0 0.100 21 17 IS 
MNZ 2.17 172.0 → 128.0d 0.040 20 14 MNZ-13C2,15N2 
172.0 → 82.0 23 
MNZ-13C2,15N2 2.17 176.0 → 132.0 0.040 21 14 IS 
RNZ 2.14 
 
200.9 → 139.9d 0.040 16 11 RNZ-D3 
200.9 → 55.0  20 
RNZ-D3 2.12 203.9 → 142.9 0.040 16 11 IS 
a TR, retention time. b CE, collision energy. c IS, internal standard. d Quantitation ion. 
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Table S2 
Intra- and inter-assay validation data. 
 
 Dimetridazole 
(μg kg-1) 
HMMNI 
(μg kg-1) 
Metronidazole 
(μg kg-1) 
Metronidazole-
OH 
(μg kg-1) 
Ronidazole 
(μg kg-1) 
40 
50
0 
500
0 
40 
50
0 
500
0 
40 
50
0 
500
0 
40 
50
0 
500
0 
40 
50
0 
500
0 
Intra-assay 
Mean 
(μg kg-1) 
44.
8 
53
3 
515
2 
43.
2 
53
1 
516
5 
43.
4 
51
6 
502
5 
43.
8 
52
8 
473
5 
44.
6 
52
8 
479
9 
SD (μg 
kg-1) 
1.6 7 49 1.7 11 132 
0.9 11 71 3.0 14 113 
2.5 7 203 
CV (%) 3.7 1.4 1.0 4.0 2.0 2.6 2.2 2.2 1.4 6.9 2.7 2.4 5.5 1.3 4.2 
Accurac
y (%) 
112 10
7 
103 108 10
6 
103 
109 
10
3 
101 109 
10
6 
95 
111 10
6 
96 
Inter-assay 
Mean 
(μg kg-1) 
44.
5 
53
0 
503
9 
43.
5 
52
5 
510
2 
43.
1 
51
7 
501
9 
45.
7 
52
9 
475
8 
45.
0 
52
9 
482
6 
SD (μg 
kg-1) 
2.1 17 113 5.4 17 189 
3.0 12 103 4.3 11 102 
3.0 9 153 
CV (%) 
4.7 3.3 2.2 12.
4 
3.2 3.7 
6.9 2.3 2.1 9.3 2.0 2.2 
6.7 1.8 3.2 
Accurac
y (%) 
111 10
6 
101 109 10
5 
102 
108 
10
3 
100 114 
10
6 
95 
113 10
6 
97 
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Table S3 
Method reproducibility results for cooked shrimp samples (n = 3). 
 
Sample Analyte Sample treatment Mean ± SD 
(μg kg-1) 
CV 
(%) 
1 Dimetridazole Boiling 47.8 ± 0.7 1.5 
2  Frying 130 ± 5.0 3.9 
3  Grilling 123 ± 8.0 6.7 
4 Metronidazole Boiling 4.8 ± 0.2 4.2 
5  Frying 1.3 ± 0.1 8.9 
6  Frying 2.1 ± 0.1 5.9 
7 Ronidazole Boiling 16.9 ± 0.6 3.4 
8  Frying 22.9 ± 0.7 3.1 
9  Grilling 23.3 ± 3.8 16.4 
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